Literature DB >> 24692069

Oral HHV-8 replication among women in Mombasa, Kenya.

Warren Phipps1, Misty Saracino, Stacy Selke, Meei-Li Huang, Walter Jaoko, Kishorchandra Mandaliya, Anna Wald, Corey Casper, R Scott McClelland.   

Abstract

Human herpesvirus-8 (HHV-8) replication in the oropharynx may play an important role in HHV-8 transmission and contribute to the development of Kaposi sarcoma (KS) in some individuals. Studies in the United States and Europe report high rates of HHV-8 DNA detection in saliva of HHV-8 infected men, but little is known about the natural history of HHV-8 among persons in sub-Saharan Africa, where prevalence of HHV-8 infection and KS is greatest. To address this gap, this study evaluated oral HHV-8 replication in a cohort of 40 HHV-8 seropositive Kenyan women. Study clinicians collected daily oral swabs from participants for up to 30 consecutive days, and swab samples were tested for HHV-8 DNA using quantitative, real-time polymerase chain reaction. HHV-8 was detected at least once in 27 (68%) participants, and the overall shedding rate was 23%. On days with HHV-8 detection, mean HHV-8 quantity was 4.5 log10  copies/ml. Among HIV-infected women, CD4 count ≥500 cells/mm(3) versus <500 cells/mm(3) was associated with higher HHV-8 copy number (4.8 log10  copies/ml vs. 3.4 log10  copies/ml; coef 1.2 [95% CI, 0.5-1.9]; P = 0.001) and a higher HHV-8 shedding rate (49% vs.12%; RR, 4.2 [95% CI, 0.8-21.4]; P = 0.08). No other factors were associated with HHV-8 shedding rate or copy number. The study demonstrates high rates and quantity of HHV-8 in the oropharynx of HHV-8 seropositive African women. These findings support the observation that oral replication is an essential feature of HHV-8 infection, with likely implications for HHV-8 transmission and KS pathogenesis.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  HIV-1; Kaposi sarcoma; Kaposi sarcoma-associated herpesvirus; human herpesvirus 8; viral replication

Mesh:

Substances:

Year:  2014        PMID: 24692069      PMCID: PMC4289619          DOI: 10.1002/jmv.23941

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  42 in total

1.  Epidemic Kaposi's sarcoma in female AIDS patients--a report of 23 Italian cases.

Authors:  P Benedetti; D Greco; F Figoli; U Tirelli
Journal:  AIDS       Date:  1991-04       Impact factor: 4.177

2.  Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates.

Authors:  D M Koelle; M L Huang; B Chandran; J Vieira; M Piepkorn; L Corey
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

3.  Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus.

Authors:  I Boldogh; P Szaniszlo; W A Bresnahan; C M Flaitz; M C Nichols; T Albrecht
Journal:  Clin Infect Dis       Date:  1996-08       Impact factor: 9.079

4.  Kaposi's sarcoma in women with AIDS.

Authors:  T P Cooley; L R Hirschhorn; J C O'Keane
Journal:  AIDS       Date:  1996-09       Impact factor: 4.177

5.  Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.

Authors:  G R Simpson; T F Schulz; D Whitby; P M Cook; C Boshoff; L Rainbow; M R Howard; S J Gao; R A Bohenzky; P Simmonds; C Lee; A de Ruiter; A Hatzakis; R S Tedder; I V Weller; R A Weiss; P S Moore
Journal:  Lancet       Date:  1996-10-26       Impact factor: 79.321

6.  Human herpesvirus 8 detection in nasal secretions and saliva.

Authors:  D J Blackbourn; E T Lennette; J Ambroziak; D V Mourich; J A Levy
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

7.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.

Authors:  S J Gao; L Kingsley; M Li; W Zheng; C Parravicini; J Ziegler; R Newton; C R Rinaldo; A Saah; J Phair; R Detels; Y Chang; P S Moore
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

8.  The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women.

Authors:  D H Kedes; D Ganem; N Ameli; P Bacchetti; R Greenblatt
Journal:  JAMA       Date:  1997-02-12       Impact factor: 56.272

9.  AIDS-associated Kaposi's sarcoma in female patients.

Authors:  K Lassoued; J P Clauvel; S Fegueux; S Matheron; I Gorin; E Oksenhendler
Journal:  AIDS       Date:  1991-07       Impact factor: 4.177

10.  Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.

Authors:  D Whitby; M R Howard; M Tenant-Flowers; N S Brink; A Copas; C Boshoff; T Hatzioannou; F E Suggett; D M Aldam; A S Denton
Journal:  Lancet       Date:  1995-09-23       Impact factor: 79.321

View more
  9 in total

1.  High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.

Authors:  Cornelia Feiterna-Sperling; Christoph Königs; Gundula Notheis; Bernd Buchholz; Renate Krüger; Katharina Weizsäcker; Josef Eberle; Nikola Hanhoff; Barbara Gärtner; Harald Heider; Detlev H Krüger; Jörg Hofmann
Journal:  Med Microbiol Immunol       Date:  2016-05-30       Impact factor: 3.402

Review 2.  Malignancies in women with HIV infection.

Authors:  Nora T Oliver; Elizabeth Y Chiao
Journal:  Curr Opin HIV AIDS       Date:  2017-01       Impact factor: 4.283

3.  Oral shedding of herpesviruses in HIV-infected patients with varying degrees of immune status.

Authors:  Dirk P Dittmer; Kristen Tamburro; Huichao Chen; Anthony Lee; Marcia K Sanders; Tischan A Wade; Sonia Napravnik; Jennifer Webster-Cyriaque; Mahmoud Ghannoum; Caroline H Shiboski; Judith A Aberg
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

Review 4.  Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus.

Authors:  Veenu Minhas; Charles Wood
Journal:  Viruses       Date:  2014-11-04       Impact factor: 5.048

5.  Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons.

Authors:  Rachel A Bender Ignacio; Jason D Goldman; Amalia S Magaret; Stacy Selke; Meei-Li Huang; Soren Gantt; Christine Johnston; Warren T Phipps; Joshua T Schiffer; Richard A Zuckerman; R Scott McClelland; Connie Celum; Larry Corey; Anna Wald; Corey Casper
Journal:  Infect Agent Cancer       Date:  2016-02-10       Impact factor: 2.965

6.  Prospective study of human herpesvirus 8 oral shedding, viremia, and serological status among human immunodeficiency virus seropositive and seronegative individuals in Sao Paulo, Brazil.

Authors:  Paulo H Braz-Silva; Tania R Tozetto-Mendoza; Laura M Sumita; Wilton Freire; Michelle Palmieri; Alan M do Canto; Vivian I Avelino-Silva; Marina Gallottini; Philippe Mayaud; Claudio S Pannuti
Journal:  J Oral Microbiol       Date:  2017-10-15       Impact factor: 5.474

7.  Intra-host changes in Kaposi sarcoma-associated herpesvirus genomes in Ugandan adults with Kaposi sarcoma.

Authors:  Jan Clement Santiago; Jason D Goldman; Hong Zhao; Alec P Pankow; Fred Okuku; Michael W Schmitt; Lennie H Chen; C Alexander Hill; Corey Casper; Warren T Phipps; James I Mullins
Journal:  PLoS Pathog       Date:  2021-01-19       Impact factor: 6.823

Review 8.  KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine.

Authors:  Corey Casper; Lawrence Corey; Jeffrey I Cohen; Blossom Damania; Anne A Gershon; David C Kaslow; Laurie T Krug; Jeffrey Martin; Sam M Mbulaiteye; Edward S Mocarski; Patrick S Moore; Javier Gordon Ogembo; Warren Phipps; Denise Whitby; Charles Wood
Journal:  NPJ Vaccines       Date:  2022-09-20       Impact factor: 9.399

9.  Kaposi's sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands.

Authors:  Angela Nalwoga; Emily L Webb; Belinda Chihota; Wendell Miley; Bridgious Walusimbi; Jacent Nassuuna; Richard E Sanya; Gyaviira Nkurunungi; Nazzarena Labo; Alison M Elliott; Stephen Cose; Denise Whitby; Robert Newton
Journal:  PLoS Negl Trop Dis       Date:  2019-10-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.